Meir Medical Center in Kfar Saba, Israel is recruiting Crohn’s Disease sufferers for a study on the ability of cannabis to treat the inflammatory bowel disease. According to the U.S. National Institutes of Health’s ClinicalTrials.gov, researchers with Meir are currently recruiting participants for phase 1 and 2 studies of the effectiveness of pot molecules THC and CBD on the painful, diarrhea- and vomiting-inducing GI tract illness, which affects 400,000-600,000 North Americans.
FOLLOW US